RFA-DK-20-028: Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2021.
National Institutes of Health offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on October 25, 2021.
From the official notice on Grants.gov, last changed September 28, 2021. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeCooperative Agreement
About this NIH notice
- Activity codeU01
- Clinical trialsNot allowed
- Funded byNIDDK
- Median yearly award$641,448
- Typical project length10 years
- U01, Research Project Cooperative Agreement. Like an R01, but NIH staff are substantially involved in the work. Other open U01 notices.
Projects funded under RFA-DK-20-028 were run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, 7 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read RFA-DK-20-028 in the NIH Guide.
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| RFA-DK-27-302 | June 3, 2026 | Closed July 10, 2026 | Closed |
Key dates
| Posted | April 22, 2021 |
|---|---|
| Deadline | October 25, 2021 |
| Archived by Grants.gov | November 24, 2021 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
All 15 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Is this a realistic fit?
- Most of the program's money (70% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
This Funding Opportunity Announcement (FOA) requests applications for the Kidney Precision Medicine Project (KPMP) - Tissue Interrogation Sites (TIS) to analyze human kidney tissue. The TIS will collaborate with the Recruitment Sites (RS), Kidney Tissue Atlas Coordinating Center (KTACC) and Central Hub (CH) to obtain and evaluate kidney biopsies from participants with acute kidney injury (AKI) or chronic kidney disease (CKD), create a Kidney Tissue Atlas, define disease subgroups, and identify critical cells, interstitial components, pathways, and targets for novel therapies.
Funded under RFA-DK-20-028 so far
NIH funded 7 projects under RFA-DK-20-028 in fiscal 2022 to 2026, at 7 institutions. The median yearly award was $641,448.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Spatial Elucidation of Human Acute Kidney Injury and Chronic Kidney Disease using Imaging Mass Cytometry | Yale University | 2026 | $306,691 |
| Multimodal Imaging Mass Spectrometry and Spatial Omics for the Human Kidney | Vanderbilt University | 2026 | $729,455 |
| Single cell multiomic and spatial atlas of acute and chronic kidney injury | Washington University | 2026 | $1.0 million |
| PREcision Medicine through IntErrogation of Rna in the kidnEy (PREMIERE) | University of Michigan at Ann Arbor | 2026 | $627,449 |
| Spatial Mapping of Proteomic and Transcriptional Signatures in Kidney Disease | University of Colorado Denver | 2026 | $1 |
| Integrated spatial interrogation of cellular and molecular signatures of human kidney disease | Indiana University Indianapolis | 2026 | $1.3 million |
| Spatial Multi-Omics to Profile Metabolic Pathways for Kidney Disease | University of Texas HLTH Science Center | 2026 | $619,452 |
Who has won Diabetes, Digestive, and Kidney Diseases Extramural Research grants before
From fiscal 2021 to 2025, Diabetes, Digestive, and Kidney Diseases Extramural Research (93.847) awarded $9.6 billion across 7,877 grant awards, an average of $1.2 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Regents of the University of Michigan | Michigan | 273 | $345 million |
| The Trustees of the University of Pennsylvania | Pennsylvania | 187 | $272 million |
| University of Pittsburgh - of the Commonwealth System of Higher Education | Pennsylvania | 209 | $238 million |
| The Washington University | Missouri | 187 | $227 million |
| The Regents of the University of California, San Francisco | California | 176 | $208 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-DK-20-028 still open?
No. It closed on October 25, 2021.
Who can apply for Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed)?
National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed)?
Closed October 25, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has been funded under RFA-DK-20-028?
NIH RePORTER lists 7 projects funded under RFA-DK-20-028 in fiscal 2022 to 2026, at 7 institutions. The most were at Yale University, Vanderbilt University, Washington University.
Who has won Diabetes, Digestive, and Kidney Diseases Extramural Research grants before?
The largest recipients over five fiscal years were Regents of the University of Michigan, The Trustees of the University of Pennsylvania, University of Pittsburgh - of the Commonwealth System of Higher Education. The program made 7,877 awards worth $9.6 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)
- Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)
- Opportunities for Collaborative Research with the NIH Intramural Research Program (U01 Clinical Trial Optional)